The Immune Response Corporation Completes Enrollment for Phase II/III HIV Therapeutic Vaccine Clinical Trial

For full access to this item, please log in.

Title: The Immune Response Corporation Completes Enrollment for Phase II/III HIV Therapeutic Vaccine Clinical Trial
Author: Immune Response Corporation
Publication: The Immune Response Corporation; 1991-09-10
Rights/Permissions: The University of Michigan Library provides access to these materials for educational and research purposes, with permission from their copyright holder(s). If you decide to use any of these materials, you are responsible for making your own legal assessment and securing any necessary permission.
Subject terms: press releases
Series/Folder Title: Marketplace > Companies > Immune Response Corporation > General
Item type:: press releases
Link to this Item: https://quod.lib.umich.edu/c/cohenaids/5571095.0516.084
Cite this Item: "The Immune Response Corporation Completes Enrollment for Phase II/III HIV Therapeutic Vaccine Clinical Trial." In the digital collection Jon Cohen AIDS Research Collection. https://quod.lib.umich.edu/c/cohenaids/5571095.0516.084. University of Michigan Library Digital Collections. Accessed June 25, 2025.

Contents